Global β-Interferon Supply, Demand and Key Producers, 2023-2029

Description

The global β-Interferon market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

β-Interferon is a type I interferon. It is produced by various cells such as fibroblasts after induction by viruses and nucleic acids.

This report studies the global β-Interferon demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for β-Interferon, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of β-Interferon that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global β-Interferon total market, 2018-2029, (USD Million)
Global β-Interferon total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: β-Interferon total market, key domestic companies and share, (USD Million)
Global β-Interferon revenue by player and market share 2018-2023, (USD Million)
Global β-Interferon total market by Type, CAGR, 2018-2029, (USD Million)
Global β-Interferon total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global β-Interferon market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Roche, SP (Brinny) Company, Anke Bio, Sinopharm, Kexing Biopharm, Kawin, Hainan Unipul Pharmaceutical and Tri-Prime Gene, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World β-Interferon market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global β-Interferon Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global β-Interferon Market, Segmentation by Type
    Injection
    Topical

Global β-Interferon Market, Segmentation by Application
    Hospital
    Clinics
    Drug Store
    Others

Companies Profiled:
    Merck
    Roche
    SP (Brinny) Company
    Anke Bio
    Sinopharm
    Kexing Biopharm
    Kawin
    Hainan Unipul Pharmaceutical
    Tri-Prime Gene
    Amoytop Biotech
    Changchun Institute of Biological Products

Key Questions Answered
1. How big is the global β-Interferon market?
2. What is the demand of the global β-Interferon market?
3. What is the year over year growth of the global β-Interferon market?
4. What is the total value of the global β-Interferon market?
5. Who are the major players in the global β-Interferon market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 β-Interferon Introduction
    1.2 World β-Interferon Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World β-Interferon Total Market by Region (by Headquarter Location)
        1.3.1 World β-Interferon Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States β-Interferon Market Size (2018-2029)
        1.3.3 China β-Interferon Market Size (2018-2029)
        1.3.4 Europe β-Interferon Market Size (2018-2029)
        1.3.5 Japan β-Interferon Market Size (2018-2029)
        1.3.6 South Korea β-Interferon Market Size (2018-2029)
        1.3.7 ASEAN β-Interferon Market Size (2018-2029)
        1.3.8 India β-Interferon Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 β-Interferon Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 β-Interferon Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World β-Interferon Consumption Value (2018-2029)
    2.2 World β-Interferon Consumption Value by Region
        2.2.1 World β-Interferon Consumption Value by Region (2018-2023)
        2.2.2 World β-Interferon Consumption Value Forecast by Region (2024-2029)
    2.3 United States β-Interferon Consumption Value (2018-2029)
    2.4 China β-Interferon Consumption Value (2018-2029)
    2.5 Europe β-Interferon Consumption Value (2018-2029)
    2.6 Japan β-Interferon Consumption Value (2018-2029)
    2.7 South Korea β-Interferon Consumption Value (2018-2029)
    2.8 ASEAN β-Interferon Consumption Value (2018-2029)
    2.9 India β-Interferon Consumption Value (2018-2029)

3 World β-Interferon Companies Competitive Analysis
    3.1 World β-Interferon Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global β-Interferon Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for β-Interferon in 2022
        3.2.3 Global Concentration Ratios (CR8) for β-Interferon in 2022
    3.3 β-Interferon Company Evaluation Quadrant
    3.4 β-Interferon Market: Overall Company Footprint Analysis
        3.4.1 β-Interferon Market: Region Footprint
        3.4.2 β-Interferon Market: Company Product Type Footprint
        3.4.3 β-Interferon Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: β-Interferon Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: β-Interferon Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: β-Interferon Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: β-Interferon Consumption Value Comparison
        4.2.1 United States VS China: β-Interferon Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: β-Interferon Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based β-Interferon Companies and Market Share, 2018-2023
        4.3.1 United States Based β-Interferon Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies β-Interferon Revenue, (2018-2023)
    4.4 China Based Companies β-Interferon Revenue and Market Share, 2018-2023
        4.4.1 China Based β-Interferon Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies β-Interferon Revenue, (2018-2023)
    4.5 Rest of World Based β-Interferon Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based β-Interferon Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies β-Interferon Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World β-Interferon Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Injection
        5.2.2 Topical
    5.3 Market Segment by Type
        5.3.1 World β-Interferon Market Size by Type (2018-2023)
        5.3.2 World β-Interferon Market Size by Type (2024-2029)
        5.3.3 World β-Interferon Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World β-Interferon Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinics
        6.2.3 Drug Store
        6.2.4 Others
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World β-Interferon Market Size by Application (2018-2023)
        6.3.2 World β-Interferon Market Size by Application (2024-2029)
        6.3.3 World β-Interferon Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Merck
        7.1.1 Merck Details
        7.1.2 Merck Major Business
        7.1.3 Merck β-Interferon Product and Services
        7.1.4 Merck β-Interferon Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Merck Recent Developments/Updates
        7.1.6 Merck Competitive Strengths & Weaknesses
    7.2 Roche
        7.2.1 Roche Details
        7.2.2 Roche Major Business
        7.2.3 Roche β-Interferon Product and Services
        7.2.4 Roche β-Interferon Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Roche Recent Developments/Updates
        7.2.6 Roche Competitive Strengths & Weaknesses
    7.3 SP (Brinny) Company
        7.3.1 SP (Brinny) Company Details
        7.3.2 SP (Brinny) Company Major Business
        7.3.3 SP (Brinny) Company β-Interferon Product and Services
        7.3.4 SP (Brinny) Company β-Interferon Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 SP (Brinny) Company Recent Developments/Updates
        7.3.6 SP (Brinny) Company Competitive Strengths & Weaknesses
    7.4 Anke Bio
        7.4.1 Anke Bio Details
        7.4.2 Anke Bio Major Business
        7.4.3 Anke Bio β-Interferon Product and Services
        7.4.4 Anke Bio β-Interferon Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Anke Bio Recent Developments/Updates
        7.4.6 Anke Bio Competitive Strengths & Weaknesses
    7.5 Sinopharm
        7.5.1 Sinopharm Details
        7.5.2 Sinopharm Major Business
        7.5.3 Sinopharm β-Interferon Product and Services
        7.5.4 Sinopharm β-Interferon Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Sinopharm Recent Developments/Updates
        7.5.6 Sinopharm Competitive Strengths & Weaknesses
    7.6 Kexing Biopharm
        7.6.1 Kexing Biopharm Details
        7.6.2 Kexing Biopharm Major Business
        7.6.3 Kexing Biopharm β-Interferon Product and Services
        7.6.4 Kexing Biopharm β-Interferon Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Kexing Biopharm Recent Developments/Updates
        7.6.6 Kexing Biopharm Competitive Strengths & Weaknesses
    7.7 Kawin
        7.7.1 Kawin Details
        7.7.2 Kawin Major Business
        7.7.3 Kawin β-Interferon Product and Services
        7.7.4 Kawin β-Interferon Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Kawin Recent Developments/Updates
        7.7.6 Kawin Competitive Strengths & Weaknesses
    7.8 Hainan Unipul Pharmaceutical
        7.8.1 Hainan Unipul Pharmaceutical Details
        7.8.2 Hainan Unipul Pharmaceutical Major Business
        7.8.3 Hainan Unipul Pharmaceutical β-Interferon Product and Services
        7.8.4 Hainan Unipul Pharmaceutical β-Interferon Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Hainan Unipul Pharmaceutical Recent Developments/Updates
        7.8.6 Hainan Unipul Pharmaceutical Competitive Strengths & Weaknesses
    7.9 Tri-Prime Gene
        7.9.1 Tri-Prime Gene Details
        7.9.2 Tri-Prime Gene Major Business
        7.9.3 Tri-Prime Gene β-Interferon Product and Services
        7.9.4 Tri-Prime Gene β-Interferon Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Tri-Prime Gene Recent Developments/Updates
        7.9.6 Tri-Prime Gene Competitive Strengths & Weaknesses
    7.10 Amoytop Biotech
        7.10.1 Amoytop Biotech Details
        7.10.2 Amoytop Biotech Major Business
        7.10.3 Amoytop Biotech β-Interferon Product and Services
        7.10.4 Amoytop Biotech β-Interferon Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Amoytop Biotech Recent Developments/Updates
        7.10.6 Amoytop Biotech Competitive Strengths & Weaknesses
    7.11 Changchun Institute of Biological Products
        7.11.1 Changchun Institute of Biological Products Details
        7.11.2 Changchun Institute of Biological Products Major Business
        7.11.3 Changchun Institute of Biological Products β-Interferon Product and Services
        7.11.4 Changchun Institute of Biological Products β-Interferon Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Changchun Institute of Biological Products Recent Developments/Updates
        7.11.6 Changchun Institute of Biological Products Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 β-Interferon Industry Chain
    8.2 β-Interferon Upstream Analysis
    8.3 β-Interferon Midstream Analysis
    8.4 β-Interferon Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World β-Interferon Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World β-Interferon Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World β-Interferon Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World β-Interferon Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World β-Interferon Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World β-Interferon Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World β-Interferon Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World β-Interferon Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World β-Interferon Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key β-Interferon Players in 2022
    Table 12. World β-Interferon Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global β-Interferon Company Evaluation Quadrant
    Table 14. Head Office of Key β-Interferon Player
    Table 15. β-Interferon Market: Company Product Type Footprint
    Table 16. β-Interferon Market: Company Product Application Footprint
    Table 17. β-Interferon Mergers & Acquisitions Activity
    Table 18. United States VS China β-Interferon Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China β-Interferon Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based β-Interferon Companies, Headquarters (States, Country)
    Table 21. United States Based Companies β-Interferon Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies β-Interferon Revenue Market Share (2018-2023)
    Table 23. China Based β-Interferon Companies, Headquarters (Province, Country)
    Table 24. China Based Companies β-Interferon Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies β-Interferon Revenue Market Share (2018-2023)
    Table 26. Rest of World Based β-Interferon Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies β-Interferon Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies β-Interferon Revenue Market Share (2018-2023)
    Table 29. World β-Interferon Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World β-Interferon Market Size by Type (2018-2023) & (USD Million)
    Table 31. World β-Interferon Market Size by Type (2024-2029) & (USD Million)
    Table 32. World β-Interferon Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World β-Interferon Market Size by Application (2018-2023) & (USD Million)
    Table 34. World β-Interferon Market Size by Application (2024-2029) & (USD Million)
    Table 35. Merck Basic Information, Area Served and Competitors
    Table 36. Merck Major Business
    Table 37. Merck β-Interferon Product and Services
    Table 38. Merck β-Interferon Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Merck Recent Developments/Updates
    Table 40. Merck Competitive Strengths & Weaknesses
    Table 41. Roche Basic Information, Area Served and Competitors
    Table 42. Roche Major Business
    Table 43. Roche β-Interferon Product and Services
    Table 44. Roche β-Interferon Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Roche Recent Developments/Updates
    Table 46. Roche Competitive Strengths & Weaknesses
    Table 47. SP (Brinny) Company Basic Information, Area Served and Competitors
    Table 48. SP (Brinny) Company Major Business
    Table 49. SP (Brinny) Company β-Interferon Product and Services
    Table 50. SP (Brinny) Company β-Interferon Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. SP (Brinny) Company Recent Developments/Updates
    Table 52. SP (Brinny) Company Competitive Strengths & Weaknesses
    Table 53. Anke Bio Basic Information, Area Served and Competitors
    Table 54. Anke Bio Major Business
    Table 55. Anke Bio β-Interferon Product and Services
    Table 56. Anke Bio β-Interferon Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Anke Bio Recent Developments/Updates
    Table 58. Anke Bio Competitive Strengths & Weaknesses
    Table 59. Sinopharm Basic Information, Area Served and Competitors
    Table 60. Sinopharm Major Business
    Table 61. Sinopharm β-Interferon Product and Services
    Table 62. Sinopharm β-Interferon Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Sinopharm Recent Developments/Updates
    Table 64. Sinopharm Competitive Strengths & Weaknesses
    Table 65. Kexing Biopharm Basic Information, Area Served and Competitors
    Table 66. Kexing Biopharm Major Business
    Table 67. Kexing Biopharm β-Interferon Product and Services
    Table 68. Kexing Biopharm β-Interferon Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Kexing Biopharm Recent Developments/Updates
    Table 70. Kexing Biopharm Competitive Strengths & Weaknesses
    Table 71. Kawin Basic Information, Area Served and Competitors
    Table 72. Kawin Major Business
    Table 73. Kawin β-Interferon Product and Services
    Table 74. Kawin β-Interferon Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Kawin Recent Developments/Updates
    Table 76. Kawin Competitive Strengths & Weaknesses
    Table 77. Hainan Unipul Pharmaceutical Basic Information, Area Served and Competitors
    Table 78. Hainan Unipul Pharmaceutical Major Business
    Table 79. Hainan Unipul Pharmaceutical β-Interferon Product and Services
    Table 80. Hainan Unipul Pharmaceutical β-Interferon Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Hainan Unipul Pharmaceutical Recent Developments/Updates
    Table 82. Hainan Unipul Pharmaceutical Competitive Strengths & Weaknesses
    Table 83. Tri-Prime Gene Basic Information, Area Served and Competitors
    Table 84. Tri-Prime Gene Major Business
    Table 85. Tri-Prime Gene β-Interferon Product and Services
    Table 86. Tri-Prime Gene β-Interferon Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Tri-Prime Gene Recent Developments/Updates
    Table 88. Tri-Prime Gene Competitive Strengths & Weaknesses
    Table 89. Amoytop Biotech Basic Information, Area Served and Competitors
    Table 90. Amoytop Biotech Major Business
    Table 91. Amoytop Biotech β-Interferon Product and Services
    Table 92. Amoytop Biotech β-Interferon Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Amoytop Biotech Recent Developments/Updates
    Table 94. Changchun Institute of Biological Products Basic Information, Area Served and Competitors
    Table 95. Changchun Institute of Biological Products Major Business
    Table 96. Changchun Institute of Biological Products β-Interferon Product and Services
    Table 97. Changchun Institute of Biological Products β-Interferon Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 98. Global Key Players of β-Interferon Upstream (Raw Materials)
    Table 99. β-Interferon Typical Customers
List of Figure
    Figure 1. β-Interferon Picture
    Figure 2. World β-Interferon Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World β-Interferon Total Market Size (2018-2029) & (USD Million)
    Figure 4. World β-Interferon Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World β-Interferon Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company β-Interferon Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company β-Interferon Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company β-Interferon Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company β-Interferon Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company β-Interferon Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company β-Interferon Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company β-Interferon Revenue (2018-2029) & (USD Million)
    Figure 13. β-Interferon Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World β-Interferon Consumption Value (2018-2029) & (USD Million)
    Figure 16. World β-Interferon Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States β-Interferon Consumption Value (2018-2029) & (USD Million)
    Figure 18. China β-Interferon Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe β-Interferon Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan β-Interferon Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea β-Interferon Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN β-Interferon Consumption Value (2018-2029) & (USD Million)
    Figure 23. India β-Interferon Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of β-Interferon by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for β-Interferon Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for β-Interferon Markets in 2022
    Figure 27. United States VS China: β-Interferon Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: β-Interferon Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World β-Interferon Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World β-Interferon Market Size Market Share by Type in 2022
    Figure 31. Injection
    Figure 32. Topical
    Figure 33. World β-Interferon Market Size Market Share by Type (2018-2029)
    Figure 34. World β-Interferon Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World β-Interferon Market Size Market Share by Application in 2022
    Figure 36. Hospital
    Figure 37. Clinics
    Figure 38. Drug Store
    Figure 39. Others
    Figure 40. β-Interferon Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source